Lederle   Report issue

Contributed to NME For profit Phase 2
Founded: New York NY United States (1906)
Status: Acquired by American Cyanamid (1930) → now Pfizer (2009)

Organization Overview

First Clinical Trial
1999
NCT00002259
First Marketed Drug
1941
sulfazine
First NDA Approval
1941
sulfadiazine
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ESI LEDERLE | LEDERLE | Lederle Laboratories